BaseSpace
Correlation
Engine-Public
Sign In
Register
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
BRCA1
,
calcium channel activity
,
Lung cancer
,
Intestine
,
DNA fingerprint
,
Doxorubicin
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
HLA E
Summary
General Info
Curated Studies
Most Correlated Studies
Peripheral blood monocytes response to soluble MHC Class II
Monocytes and B cells of HIV-1 high risk persons vaccinated with DNA/rAd5 with HIV-1 acquisition
CD8+ naive or activated T cells from PBMCs of dengue or dengue hemorrhagic patients
Macrophages infected with Salmonella typhimurium or Listeria monocytogenes
Monocytic myeloid-derived suppressor cells and monocytes from HNSCC patients
Explore Curated Studies Results
Literature
Most Relevant Literature
The antibodies 3D12 and 4D12 recognise distinct epitopes and conformations of HLA-E.
Dynamic Alteration in HLA-E Expression and Soluble HLA-E via Interaction with Natural Killer Cells i…
HLA-E-restricted SARS-CoV-2-specific T cells from convalescent COVID-19 patients suppress virus repl…
Is HLA-E with its receptors an immune checkpoint or an antigenic determinant in allo-HCT?
Mouse and human antibodies bind HLA-E-leader peptide complexes and enhance NK cell cytotoxicity.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Impact of HLA-E Overexpression by Tumor Cells on the Biology of TIL in Colorectal Cancer
Evaluation of Desensitization Protocols in HLA-incompatible Kidney-transplant Candidates
Safety Study of Peptide Cancer Vaccine To Treat HLA-A*02-positive Advanced Non-small Cell Lung Cance…
Safety and Efficacy Study of Epitope Peptide To Treat HLA-A*24 or A*02-positive Advanced Solid Tumor…
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Leukapheresis for CAR T- Cell Manufact…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ